Pirfenidone Clonmel

Clonmel Healthcare is delighted to announce the launch of Pirfenidone Clonmel 267mg and 801mg film-coated tablets.

Pirfenidone Clonmel is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF).

Full prescribing information is available on request or alternatively please go to www.clonmel-health.ie.  Medicinal product subject to medical prescription.

Please contact Clonmel Healthcare on 01-6204000 if you require any additional information.

PA 126/350/1-2. PA Holder: Clonmel Healthcare Ltd., Clonmel, Co. Tipperary. Date prepared: November 2022. 2022/ADV/PIR/287H.